Kiniksa Reports Third Quarter 2018 Financial Results and Pipeline Progress
01. November 2018 08:00 ET
|
Kiniksa Pharmaceuticals, Ltd.
– Rilonacept pivotal Phase 3 clinical trial initiating this year– Mavrilimumab pre-IND meeting complete; plans for global Phase 2 clinical trial advancing– KPL-716 advancing into multiple chronic...
ATN Reports Third Quarter 2018 Results
24. Oktober 2018 17:11 ET
|
ATN International, Inc.
- Another Quarter of Sequential Earnings Growth- Restoration of US Virgin Islands Network Almost Complete Third Quarter Financial Highlights: Revenues: $121.1 millionAdjusted EBITDA1: $38.9...
ATN Sets Date To Report Third Quarter 2018 Results
11. Oktober 2018 16:15 ET
|
ATN International, Inc.
Investor Conference Call Scheduled BEVERLY, Mass., Oct. 11, 2018 (GLOBE NEWSWIRE) -- ATN (NASDAQ:ATNI) announced today that it will report results for the third quarter ended September 30, 2018 on...